Lansoprazole Capsule, Delayed Release
Product Images NDC 68001-112

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68001-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole Dr Capsules Usp 15mg 90ct Rev 05-17 (Lansoprazole Capsules 15mg 30s)

This is a description of a drug called Lansoprazole manufactured by Dr. Reddy's Laboratories Limited in India. The drug comes in Delayed-Release Exch capsules that contain 15g of Lansoprazole USP. The capsules are identified with the letters "RDY" and "LAN". The medication guide should be given to each patient, and the capsules should be dispensed in a tightly sealed container by a pharmacist. The product identification and other details can be found in the enclosed brochure. The rest of the text cannot be understood.*

FDA Label Image

Lansoprazole Dr Capsules Usp 30 mg 30ct (Lansoprazole Capsules 30mg 90s)

This is a description for Lansoprazole delayed release capsules. The text contains information on the drug manufacturer, dosage (70mg), container size (30 capsules), and prescription requirement, as well as a warning not to accept a seal over the bottle if the opening is missing or broken. It also includes directions to dispense accompanying medication guides to each patient and to store the capsules at room temperature.*

FDA Label Image

Figure 1 (Image 01)

FDA Label Image

Figure 2 (Image 02)

FDA Label Image

Chemical Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.